<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview and differential diagnosis of papilledema
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview and differential diagnosis of papilledema
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview and differential diagnosis of papilledema
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Don C Bienfang, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul W Brazis, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Janet L Wilterdink, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 10, 2019.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         While the term "papilledema" is often used broadly to denote a swollen optic nerve head, the term "papilledema" should be reserved for optic disc swelling that is due to raised intracranial pressure.
        </p>
        <p>
         This topic will provide an overview and differential diagnosis of papilledema. The entity of increased intracranial pressure and specific causes of papilledema are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ETIOLOGIES AND PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Papilledema occurs when raised intracranial pressure is transmitted to the optic nerve sheath. The raised pressure mechanically disrupts axoplasmic flow within the nerve. Obstipation of intra-axonal fluid results in swelling of the axons and leakage of water, protein, and other cellular contents into the extracellular space of the optic disc giving rise to optic disc edema [
         <a href="#rid1">
          1,2
         </a>
         ]. Venous obstruction and dilation, nerve fiber ischemia, and vascular telangiectasias are secondary phenomena.
        </p>
        <p>
         Any entity that increases intracranial pressure may lead to papilledema. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intracranial mass lesions (eg, tumor, hematoma)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral edema (such as in acute hypoxic-ischemic encephalopathy, large cerebral infarction, severe traumatic brain injury)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased cerebrospinal fluid (CSF) production (eg, choroid plexus papilloma)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased CSF absorption (eg, arachnoid granulation adhesions after bacterial meningitis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstructive hydrocephalus
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstruction of venous outflow (eg, venous sinus thrombosis, jugular vein compression, neck surgery)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Idiopathic intracranial hypertension (pseudotumor cerebri)
        </p>
        <p>
        </p>
        <p>
         Rarer entities causing increased intracranial pressure include increased arterial inflow as from an arteriovenous fistula [
         <a href="#rid3">
          3,4
         </a>
         ], intraspinal lesions [
         <a href="#rid5">
          5,6
         </a>
         ], chronic respiratory illness [
         <a href="#rid7">
          7,8
         </a>
         ], and other toxic metabolic conditions that cause diffuse cerebral edema [
         <a href="#rid9">
          9
         </a>
         ]. Reported cases of papilledema in acute or chronic inflammatory demyelinating neuropathy may represent a consequence of elevated CSF protein, which may impair resorption or circulation of CSF [
         <a href="#rid10">
          10-13
         </a>
         ].
        </p>
        <p>
         Idiopathic intracranial hypertension (pseudotumor cerebri) is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5254.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5253.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Papilledema is usually discovered when a patient is evaluated for other symptoms of increased intracranial pressure, rather than for symptoms directly resulting from optic nerve pathology.
        </p>
        <p>
         Because the causes of intracranial hypertension are generalized phenomena, papilledema is almost universally bilateral, although it may be asymmetric. If there is underlying optic nerve injury or disease, then the appearance of papilledema may be unilateral, since the damaged nerve does not swell. The classic example is the Foster-Kennedy syndrome, in which a frontal lobe tumor compresses and destroys the optic nerve on one side before causing increased intracranial pressure. This gives rise to optic atrophy in one eye and disc edema in the other.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Symptoms of increased intracranial pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache is a cardinal symptom of increased intracranial pressure. However, few features of the headache specifically point to intracranial hypertension as a cause. Nausea and vomiting are frequent in this setting, but they are also a manifestation of migraine. Worrisome features include a positional quality to the headache, usually worsening with recumbency, as well as a diurnal pattern; headaches associated with intracranial hypertension are classically worse in early morning. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         .)
        </p>
        <p>
         Another classic symptom of increased intracranial pressure is binocular horizontal diplopia resulting from unilateral or bilateral lateral rectus paresis. Cranial nerve six, the abducens nerve, is believed to be peculiarly vulnerable to the effects of increased intracranial pressure because of its long course in the subarachnoid space and its bend to enter the cavernous sinus.
        </p>
        <p>
         A pulsatile machinery-like sound in the ear, probably due to venous sinus obstruction, is also common and often persistent even after the raised intracranial pressure is relieved.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Visual symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         While rarely the presenting symptom, visual symptoms are common in patients with papilledema. These are typically visual obscurations that clear completely, are often unilateral, and are typically very brief (just seconds) [
         <a href="#rid14">
          14
         </a>
         ]. They may occur spontaneously or with changes in position, and they are believed to represent transient fluctuations in nerve head perfusion. Their presence correlates with the degree of intracranial pressure elevation. Increasing intensity, frequency, and duration of these symptoms can be a prognostic sign for permanent visual loss, but this symptom is not reliably predictive.
        </p>
        <p>
         It is unusual for patients to have persistent deficits of visual acuity or field loss until quite late in the course. Untreated, chronic papilledema can lead to progressive visual field loss in the form of peripheral field contraction, nerve fiber bundle defects, and even blindness [
         <a href="#rid15">
          15,16
         </a>
         ]. The field loss often mimics the field loss of glaucoma.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Funduscopic findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because the findings in papilledema evolve over time, ophthalmologists often characterize papilledema into stages: early, fully developed, and chronic or late.
        </p>
        <p>
         Clinicians often photograph patients' fundi in order to follow changes in the examination and monitor response to treatment. Another approach might be to use a grading scheme, but some of these have not been well validated or universally accepted [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Early
         </span>
         <span class="headingEndMark">
          —
         </span>
         One of the earliest findings in papilledema is loss of spontaneous venous pulsations, occurring with pressure elevations of only 200 mm [
         <a href="#rid18">
          18-28
         </a>
         ]. This is a sensitive rather than specific sign, as 20 percent of normal individuals do not have detectable venous pulsations. These pulsations are best seen in the section of the central retinal vein that is going into the optic nerve cup.
        </p>
        <p>
         The optic cup is retained when the papilledema is mild. However, splinter hemorrhages in the nerve fiber layer, at or beyond the disc margin, may be seen early (
         <a class="graphic graphic_picture graphicRef72814" href="/z/d/graphic/72814.html" rel="external">
          picture 1
         </a>
         ). This is also a nonspecific sign, especially in older patients [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Fully developed
         </span>
         <span class="headingEndMark">
          —
         </span>
         As the edema progress, the optic disc becomes elevated, the cup is obliterated, and the disc margins become obscured. Blood vessels are buried as they course the disc. Serpentine engorgement of retinal veins is evident, and the disc appears hyperemic. The edema extends into the retina, giving the appearance of an enlarged optic nerve head. Multiple flame hemorrhages and cotton wool spots, resulting from nerve fiber infarction, appear. Retinal microfolds form around the swollen disc. At this stage, the blind spot will be increased (
         <a class="graphic graphic_picture graphicRef64616" href="/z/d/graphic/64616.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Chronic
         </span>
         <span class="headingEndMark">
          —
         </span>
         The central cup remains obliterated. Hemorrhagic and exudative components resolve. The appearance of hard exudates in the nerve fiber layer indicate a process of some months' duration. The nerve now appears flat with irregular margins; nerve fiber attrition leads to disc pallor (
         <a class="graphic graphic_picture graphicRef68815" href="/z/d/graphic/68815.html" rel="external">
          picture 3
         </a>
         ). One usually can detect some loss of visual field at this stage.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are many causes of an elevated optic nerve head. While the term "papilledema" is sometimes used to describe the findings in these conditions, it should be reserved for patients who have elevated disc heads as a consequence of increased intracranial pressure. The causes of papilledema (ie, increased intracranial pressure) are listed above. (See
         <a class="local">
          'Etiologies and pathogenesis'
         </a>
         above.)
        </p>
        <p>
         While there is overlap between the two categories, it is useful to consider those conditions that cause bilateral abnormalities versus those that are more usually unilateral (
         <a class="graphic graphic_table graphicRef54401" href="/z/d/graphic/54401.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Bilateral disc abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Funduscopic findings, the clinical setting, and the presence of associated visual loss may help distinguish the following entities from true papilledema.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pseudopapilledema – Congenital anomalies of the disc, including drusen and myelinated nerve fibers, and even farsightedness or hyperopia, may cause the appearance of disc swelling or pseudopapilledema. This term is reserved for conditions that are not due to disease states.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Drusen are hyaline bodies thought to be remnants of calcific axonal degeneration. Drusen tend to be buried in children (sometimes raising concern for increased intracranial pressure) and become more exposed in adults. Most, 75 to 85 percent, are bilateral [
         <a href="#rid29">
          29,30
         </a>
         ]. Present in approximately 2 percent of the population, they may be inherited as an autosomal dominant condition. Usually asymptomatic, some will have measurable visual field abnormalities, including enlarged blind spot, field constriction, and inferior nasal visual field loss. An afferent pupillary defect may be present if the condition is unilateral or asymmetric.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Disc drusen appear as a lumpy mass with refractile bodies within (
         <a class="graphic graphic_picture graphicRef72232" href="/z/d/graphic/72232.html" rel="external">
          picture 4
         </a>
         ). Another anomaly, myelinated nerve fibers are white, cover the underlying retina, and have scalloped edges. In contrast to papilledema, the appearance of the nerve fiber layer in pseudopapilledema appears normal, not hazy. The absence of spontaneous venous pulsations is not useful here, as they are often absent in pseudopapilledema. Other clues to the presence of a congenital anomaly are an absent portion (often nasal) of the nerve head and unusual patterns of the blood vessels as they emerge from the nerve head [
         <a href="#rid31">
          31
         </a>
         ]. Other signs of true papilledema, cotton wool spots, hemorrhages, hyperemia, and venous congestion are absent [
         <a href="#rid29">
          29
         </a>
         ]. Computed tomography (CT) scanning, ultrasonography, and optical coherence tomography clarify the diagnosis of drusen by revealing calcium deposits not visible on ophthalmoscopic examination.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignant hypertension – Severe systemic hypertension can cause a change in the optic nerve head that resembles papilledema. However, the swelling of the nerve head is usually mild. Recognizable hypertensive changes are seen in the vessels away from the nerve head in the posterior pole. These include hemorrhages, exudates, cotton wool spots, and even a "star" figure pointing to the fovea (
         <a class="graphic graphic_picture graphicRef78225" href="/z/d/graphic/78225.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef57183" href="/z/d/graphic/57183.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid32">
          32,33
         </a>
         ]. The optic nerve functions well, but damage to the retina can compromise vision and produce scotomata, dimming in vision, diplopia, and photopsia [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3833.html" rel="external">
          "Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3859.html" rel="external">
          "Ocular effects of hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diabetic papillopathy – While relatively benign, this is a troublesome entity to diagnose because it mimics both papilledema from raised intracranial pressure and anterior ischemic optic neuropathy (AION). Optic edema may vary from minimal to extensive with telangiectasias, hemorrhages, and macular star (
         <a class="graphic graphic_picture graphicRef63843" href="/z/d/graphic/63843.html" rel="external">
          picture 7
         </a>
         ) [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When diabetic papillopathy is bilateral or occurs in a young juvenile diabetic as traditionally described, it is not likely to be mistaken for AION [
         <a href="#rid35">
          35,36
         </a>
         ]. However, many cases are described in the literature in which the pathology is unilateral and the patient older. The prognosis is good, but during the acute phase there may be loss of central vision, enlarged blind spots, or field defects. These usually resolve. Impaired visual acuity is rare. Ischemia of the optic nerve is considered to be the probable mechanism; this process is independent of the diabetic retinopathy [
         <a href="#rid37">
          37
         </a>
         ]. The prognosis might be worse in older patients with type II diabetes [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5235.html" rel="external">
          "Diabetic papillopathy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Others – Hyperviscosity, hypotension, and blood loss have been reported to cause bilateral disc edema [
         <a href="#rid39">
          39
         </a>
         ]. Toxic optic neuropathies producing papilledema early in their course have been described with methanol,
         <a class="drug drug_general" data-topicid="9430" href="/z/d/drug information/9430.html" rel="external">
          ethambutol
         </a>
         , ethylene glycol, and other toxins [
         <a href="#rid9">
          9
         </a>
         ]. Optic atrophy emerges more rapidly in these conditions, while it tends to appear later in chronic papilledema. Bilateral disc edema may result from optic nerve compression by infiltrated extraocular muscles in severe thyroid ophthalmopathy.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Unilateral disc abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most of the entities that cause unilateral disc elevation can be broadly classified into ischemic, inflammatory, and infiltrative lesions. Because they are usually unilateral, they are not confused with true papilledema. However, in some situations, as noted below, these can be bilateral and raise concern for papilledema. Similarly, in some patients papilledema may be sufficiently asymmetric as to seem unilateral.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anterior ischemic optic neuropathy – AION may be arteritic (eg, giant cell arteritis) or nonarteritic [
         <a href="#rid28">
          28
         </a>
         ]. The latter occurs in older individuals and has been associated with atherosclerotic risk factors, particularly hypertension and diabetes. Nonarteritic AION has also been described in patients treated with phosphodiesterase-5 inhibitors such as
         <a class="drug drug_general" data-topicid="9643" href="/z/d/drug information/9643.html" rel="external">
          sildenafil
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/5256.html" rel="external">
          "Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5233.html" rel="external">
          "Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">
          "Clinical manifestations of giant cell arteritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7469.html" rel="external">
          "Treatment of male sexual dysfunction", section on 'Visual effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         AION is almost always unilateral except in giant cell arteritis. There is always immediate loss of some or all of the vision; altitudinal defects are classic. An afferent pupillary defect is common. Prognosis for vision recovery is poor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The swelling is not congested as it is with raised intracranial pressure but is usually pallid; if there are hemorrhages, they are small, splinter shaped on the edge of the disk [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Papillitis, neuroretinitis – Papillitis is optic neuritis of the anterior portion of the optic nerve. It does not have the same implications as retrobulbar neuritis to the underlying etiology. For papillitis, the underlying causes are much broader, while retrobulbar neuritis is usually due to demyelinating disease or multiple sclerosis [
         <a href="#rid41">
          41
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults", section on 'Visual symptoms'
         </a>
         ). When there is associated inflammation in the retina, as manifest by macular exudates, it is called neuroretinitis, and it is virtually never demyelinating in origin. Causes include viral syndromes, toxoplasmosis, cat scratch disease, sarcoidosis, syphilis, Lyme disease, and other vasculitides including systemic lupus erythematosus and granulomatosis with polyangiitis [
         <a href="#rid42">
          42-46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Papillitis is almost always unilateral. There is loss of vision, and the pupillary light reflex is abnormal in the affected eye. Pain, especially with eye movement, is common.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         On funduscopic examination, the nerve is diffusely swollen and congested. There are few hemorrhages, but there may be some cells in the vitreous just in front of the nerve and, in some cases, a group of yellow-white linear deposits pointing like the spokes of a wheel around the fovea of the retina (
         <a class="graphic graphic_picture graphicRef67875" href="/z/d/graphic/67875.html" rel="external">
          picture 8
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sarcoidosis – Optic nerve involvement is rarely the initial presentation of sarcoidosis [
         <a href="#rid47">
          47
         </a>
         ]. Sarcoidosis can affect the meninges and cause true papilledema. Some patients may present with a solitary sarcoid nodule of the nerve head. A yellowish mass is seen often with other typical lesions of sarcoid in the retina, conjunctiva, or anterior chamber. This is almost always unilateral. There may be loss of vision associated with this mass; occasionally, patients will be asymptomatic [
         <a href="#rid48">
          48
         </a>
         ]. Other patients with sarcoid can develop disc swelling from vasculitis, uveitis, or more subtle infiltration of the optic nerve head. (See
         <a class="medical medical_review" href="/z/d/html/4834.html" rel="external">
          "Neurologic sarcoidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central retinal vein occlusion – Occlusion or thrombosis of the central retinal vein is associated with chronic glaucoma, atherosclerotic risk factors (age, diabetes, hypertension), hyperviscosity, and coagulopathy [
         <a href="#rid49">
          49
         </a>
         ]. The cause is often unknown. (See
         <a class="medical medical_review" href="/z/d/html/15264.html" rel="external">
          "Retinal vein occlusion: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The disc is typically mildly congested. Hemorrhages are prominent and extend far beyond the posterior pole of the eye into the retinal periphery; these are much more extensive than in papilledema. Vision loss corresponds to the hemorrhages and any superimposed retinal ischemia (
         <a class="graphic graphic_picture graphicRef72976" href="/z/d/graphic/72976.html" rel="external">
          picture 9
         </a>
         ) [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Papillophlebitis – This presumed inflammatory condition occurs in young people and has a good prognosis [
         <a href="#rid51">
          51
         </a>
         ]. The nerve is swollen. Funduscopic examination suggests a mild central retinal vein occlusion. Enlargement of the blind spot correlates with the amount of retinal hemorrhage in the macula [
         <a href="#rid52">
          52
         </a>
         ]. Spontaneous improvement is common.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy – Metastatic tumors rarely invade the nerve head. Breast and lung cancers are the most common culprits; others include meningioma, glioma, hamartoma, dermoid tumors, lymphoma, and leukemia [
         <a href="#rid53">
          53,54
         </a>
         ]. The nerve head appears to be destroyed by the invading tissue (
         <a class="graphic graphic_picture graphicRef73722" href="/z/d/graphic/73722.html" rel="external">
          picture 10
         </a>
         ). Little of the normal architecture remains. When invasion or compression of the optic nerve occurs more posteriorly, it can appear similar to raised intracranial pressure. There is progressive loss of vision in all cases [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5226.html" rel="external">
          "Optic pathway glioma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Leber hereditary optic neuropathy – At the onset of the expression of this hereditary condition, the optic nerve head appears to be modestly elevated [
         <a href="#rid56">
          56
         </a>
         ]. It usually starts out in only one eye but eventually affects both. The blood vessels around the nerve have a telangiectatic appearance; however, this finding needs to be looked for carefully to be seen. There are no hemorrhages. Vision loss is always present. Profound optic atrophy then develops. In most cases, there is a history of this condition in the family. Genetic testing can confirm the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/6226.html" rel="external">
          "Neuropathies associated with hereditary disorders", section on 'Leber hereditary optic neuropathy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other causes – Disc swelling from low intraocular pressure or chronic intraocular inflammation may be seen after eye surgery (cataract surgery or glaucoma) or after injuries (often iatrogenic) to the globe [
         <a href="#rid57">
          57
         </a>
         ]. They are always unilateral and easily confirmed by measuring the eye pressure and the slit lamp examination.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         An optic neuropathy occurring 6 to 24 months after radiation therapy is often associated with disc edema at onset [
         <a href="#rid58">
          58,59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/91670.html" rel="external">
          "Delayed complications of cranial irradiation", section on 'Optic neuropathy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          DIAGNOSTIC TESTING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic testing can help differentiate papilledema from other causes of disc edema, follow the course of papilledema, and determine the underlying etiology.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Neuroimaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         When a patient presents with findings suggestive of papilledema, diagnostic evaluation should proceed expeditiously. The first step is neuroimaging of the brain. Magnetic resonance imaging (MRI) with gadolinium contrast is generally preferred, but computed tomography (CT) scan can be ordered initially if access to MRI is delayed. MRI will detect intracranial mass lesions and hydrocephalus. Additional sequences, magnetic resonance venography (MRV), can be used to detect venous obstruction in the dural sinuses and in the neck. Rarely, increased intracranial pressure may arise from spinal lesions; therefore, if this diagnosis is suggested by clinical signs or symptoms (back or neck pain, myelopathic signs, abnormal spinal fluid) an MRI of the spine should be ordered as well.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Lumbar puncture
         </span>
         <span class="headingEndMark">
          —
         </span>
         If neuroimaging is normal, lumbar puncture should be done for opening pressure and analysis. The technique of measuring the opening pressure is described elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4832.html" rel="external">
          "Lumbar puncture: Technique, contraindications, and complications in adults"
         </a>
         .)
        </p>
        <p>
         Using correct technique, elevated pressure is defined as greater than 250 mmH
         <sub>
          2
         </sub>
         0; measurements between 200 and 250 mmH
         <sub>
          2
         </sub>
         O are considered equivocal. Normal pressure levels in children are still a matter of debate. Intracranial hypertension in the absence of other cause defines the entity of idiopathic intracranial hypertension or pseudotumor cerebri. (See
         <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Lumbar puncture'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Visual field testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Formal visual field testing with perimetry is very useful in the detection of subclinical visual field abnormalities and quantifying changes over time. Visual field testing is mandatory in following the progress of the visual sequelae of papilledema and monitoring response to treatment. The size of the blind spot is an indirect measure of the degree of disc edema. Measurement in an individual patient must be done under exactly the same refractive conditions each time, as blind spot size is sensitive to refractive error. Constrictions in field perimetry and development of sector field defects are signs of impending serious visual loss. This finding is more valuable for prognosis than either symptoms or fundus appearance. The clinician should choose a perimetric technique that reliably measures the patient's visual field. Automated perimetry may not be ideal for all patients.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Fluorescein angiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="8461" href="/z/d/drug information/8461.html" rel="external">
          Fluorescein
         </a>
         angiography may be helpful in the detection of early papilledema, showing dye leakage, disc vascularity, and excess early and late disc fluorescence. Ophthalmologists, however, find it incompletely reliable, especially in equivocal situations, and usually unnecessary in this clinical setting.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Optical coherence tomography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Where available, optical coherence tomography may be useful to monitor the swelling of the nerve and also to clarify the effect upon and changes within the surrounding retina. This technique is very dependent upon the skills of the person performing the test and thus is prone to error. Modern technology (spectral rather than time based) has improved reliability.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The treatment of increased intracranial pressure is specific to the underlying etiology and is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5253.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          VISUAL PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Permanent loss of vision is a common consequence of papilledema that is untreated or unresponsive to treatment. Clinical findings predictive of visual loss are high-grade disc edema, peripapillary subretinal hemorrhages, opticociliary shunt vessels, abnormal vision at presentation, and the development of visual field loss. Anemia, old age, myopia, glaucoma, and systemic hypertension have been found to be risk factors for a poor prognosis in some studies [
         <a href="#rid60">
          60
         </a>
         ]. Progressive changes in the visual field or acuity are useful to predict patients at risk; however, vision loss sometimes occurs abruptly. Visual field loss attributed to hemorrhage can be expected to resolve.
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "papilledema" is most properly applied to optic disc edema occurring as a consequence of intracranial hypertension.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The causes of papilledema often have serious consequences for impending morbidity and mortality; hence, diagnostic evaluation is urgent. (See
         <a class="local">
          'Etiologies and pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unilateral disc edema and abnormal visual acuity at presentation suggest alternative diagnoses. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The first step in the evaluation for the cause of papilledema should be a neuroimaging study; brain magnetic resonance imaging (MRI) is preferred, but a computed tomography (CT) scan should be done if an MRI is not immediately available. (See
         <a class="local">
          'Neuroimaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lumbar puncture with measurement of opening pressure and analysis of cerebrospinal fluid (CSF) should follow a normal neuroimaging study. (See
         <a class="local">
          'Lumbar puncture'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serial clinical evaluations including measurements of visual acuity, funduscopic examination, and visual field testing with perimetry are invaluable in following the course of papilledema and response to treatment. (See
         <a class="local">
          'Visual field testing'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Minckler DS, Tso MO, Zimmerman LE. A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema. Am J Ophthalmol 1976; 82:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 1977; 95:1458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V, Newman NJ. Intracranial vascular abnormalities. Ophthalmol Clin North Am 2001; 14:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adelman JU. Headaches and papilledema secondary to dural arteriovenous malformation. Headache 1998; 38:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costello F, Kardon RH, Wall M, et al. Papilledema as the presenting manifestation of spinal schwannoma. J Neuroophthalmol 2002; 22:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amlashi SF, Riffaud L. Images in clinical medicine. Papilledema and spinal cord tumor. N Engl J Med 2004; 350:e18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brockmeier B, Burbach H, Runge M, Altenkirch H. Raised intracranial pressure in chronic respiratory disease. Lancet 1997; 349:883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000; 118:1626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delany C, Jay WM. Papilledema and abducens nerve palsy following ethylene glycol ingestion. Semin Ophthalmol 2004; 19:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morrison KE, Davies PT. Chronic inflammatory demyelinating polyneuropathy presenting with headache and papilledema. Headache 1999; 39:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas S, Tan J, Lawden M, Sampath R. Optic nerve sheath fenestration for intracranial hypertension associated with chronic inflammatory demyelinating polyneuropathy. Ophthal Plast Reconstr Surg 2004; 20:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fantin A, Feist RM, Reddy CV. Intracranial hypertension and papilloedema in chronic inflammatory demyelinating polyneuropathy. Br J Ophthalmol 1993; 77:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erşahin Y, Mutluer S, Yurtseven T. Hydrocephalus in Guillain-Barré syndrome. Clin Neurol Neurosurg 1995; 97:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984; 16:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearson PA, Baker RS, Khorram D, Smith TJ. Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry. Ophthalmology 1991; 98:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 1983; 96:654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 1982; 45:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliot RH. THE RETINAL PULSE. Br J Ophthalmol 1921; 5:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ENGEL S. Venous pulsation as a symptom of early glaucoma. Am J Ophthalmol 1946; 29:1446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hedges TR Jr, Baron EM, Hedges TR 3rd, Sinclair SH. The retinal venous pulse. Its relation to optic disc characteristics and choroidal pulse. Ophthalmology 1994; 101:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levin BE. The clinical significance of spontaneous pulsations of the retinal vein. Arch Neurol 1978; 35:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine DN. Spontaneous pulsation of the retinal veins. Microvasc Res 1998; 56:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lorentzen SE. Incidence of spontaneous venous pulsation in the retina. Acta Ophthalmol (Copenh) 1970; 48:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pines N. Some clinical notes on the nature of the retinal venous pulse. Brit J Ophthalmol 1938; 22:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walsh TJ, Garden JW, Gallagher B. Obliteration of retinal venous pulsations during elevation of cerebrospinal-fluid pressure. Am J Ophthalmol 1969; 67:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstein P. Significance of venous pulsation of the eyeground. Brit J Ophthalmol 1939; 23:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson-Noble FA. Venous pulsation. Trans Ophthalmol UK 1952; 72:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedman DI. Papilledema and pseudotumor cerebri. Ophthalmol Clin North Am 2001; 14:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis PL, Jay WM. Optic nerve head drusen. Semin Ophthalmol 2003; 18:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol 2002; 47:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg MA, Savino PJ, Glaser JS. A clinical analysis of pseudopapilledema. I. Population, laterality, acuity, refractive error, ophthalmoscopic characteristics, and coincident disease. Arch Ophthalmol 1979; 97:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee AG, Beaver HA. Acute bilateral optic disk edema with a macular star figure in a 12-year-old girl. Surv Ophthalmol 2002; 47:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spencer CG, Lip GY, Beevers DG. Recurrent malignant hypertension: a report of two cases and review of the literature. J Intern Med 1999; 246:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kishi S, Tso MO, Hayreh SS. Fundus lesions in malignant hypertension. II. A pathologic study of experimental hypertensive optic neuropathy. Arch Ophthalmol 1985; 103:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaphiades MS. The disk edema dilemma. Surv Ophthalmol 2002; 47:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu GF, Balcer LJ. Endocrine and metabolic deficiency. Ophthalmol Clin North Am 2004; 17:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavan PR, Aiello LM, Wafai MZ, et al. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol 1980; 98:2193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bayraktar Z, Alacali N, Bayraktar S. Diabetic papillopathy in type II diabetic patients. Retina 2002; 22:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V, Rucker JC, Vignal C, et al. Anemia and papilledema. Am J Ophthalmol 2003; 135:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rizzo JF 3rd, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 1991; 109:1668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KENNEDY C, CARROLL FD. Optic neuritis in children. Trans Am Acad Ophthalmol Otolaryngol 1960; 64:700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balcer LJ, Winterkorn JM, Galetta SL. Neuro-ophthalmic manifestations of Lyme disease. J Neuroophthalmol 1997; 17:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khubchandani R, Rane T, Agarwal P, et al. Bilateral neuroretinitis associated with mumps. Arch Neurol 2002; 59:1633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perrotta S, Nobili B, Grassia C, et al. Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis. Arch Ophthalmol 2003; 121:1493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labalette P, Bermond D, Dedes V, Savage C. Cat-scratch disease neuroretinitis diagnosed by a polymerase chain reaction approach. Am J Ophthalmol 2001; 132:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cinefro RJ, Frenkel M. Systemic lupus erythematosus presenting as optic neuritis. Ann Ophthalmol 1978; 10:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pelton RW, Lee AG, Orengo-Nania SD, Patrinely JR. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri. Am J Ophthalmol 1999; 127:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beardsley TL, Brown SV, Sydnor CF, et al. Eleven cases of sarcoidosis of the optic nerve. Am J Ophthalmol 1984; 97:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002; 32:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellenberger C Jr, Messner KH. Papillophlebitis: benign retinopathy resembling papilledema or papillitis. Ann Neurol 1978; 3:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lonn LI, Hoyt WF. Papillophlebitis: a cause of protracted yet benign optic disc edema. Eye Ear Nose Throat Mon 1966; 45:62 passim.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayo GL, Carter JE, McKinnon SJ. Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia. Am J Ophthalmol 2002; 134:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wabbels B, Demmler A, Seitz J, et al. Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol 2004; 242:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikaido H, Mishima H, Ono H, et al. Leukemic involvement of the optic nerve. Am J Ophthalmol 1988; 105:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikoskelainen EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996; 103:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. 1966. Retina 2003; 23:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shrieve DC, Hazard L, Boucher K, Jensen RL. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 2004; 101 Suppl 3:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol 1994; 30:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orcutt JC, Page NG, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984; 91:1303.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5241 Version 15.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/63246" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/70201" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11370570" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Intracranial vascular abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11398307" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Headaches and papilledema secondary to dural arteriovenous malformation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12352582" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Papilledema as the presenting manifestation of spinal schwannoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15141059" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Images in clinical medicine. Papilledema and spinal cord tumor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9121290" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Raised intracranial pressure in chronic respiratory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11115256" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Papilledema and obstructive sleep apnea syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15590539" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Papilledema and abducens nerve palsy following ethylene glycol ingestion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15613228" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Chronic inflammatory demyelinating polyneuropathy presenting with headache and papilledema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15266152" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Optic nerve sheath fenestration for intracranial hypertension associated with chronic inflammatory demyelinating polyneuropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8457518" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Intracranial hypertension and papilloedema in chronic inflammatory demyelinating polyneuropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7586859" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hydrocephalus in Guillain-Barrésyndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6497356" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Transient visual obscurations with elevated optic discs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2023742" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6638133" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7062066" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Swelling of the optic nerve head: a staging scheme.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18168146" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : THE RETINAL PULSE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20276980" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Venous pulsation as a symptom of early glaucoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8127575" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The retinal venous pulse. Its relation to optic disc characteristics and choroidal pulse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/619871" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The clinical significance of spontaneous pulsations of the retinal vein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9828153" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Spontaneous pulsation of the retinal veins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5536724" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Incidence of spontaneous venous pulsation in the retina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Some clinical notes on the nature of the retinal venous pulse
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5785858" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Obliteration of retinal venous pulsations during elevation of cerebrospinal-fluid pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Significance of venous pulsation of the eyeground
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Venous pulsation
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11370563" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Papilledema and pseudotumor cerebri.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15513010" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Optic nerve head drusen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12504737" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Optic disk drusen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/83135" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A clinical analysis of pseudopapilledema. I. Population, laterality, acuity, refractive error, ophthalmoscopic characteristics, and coincident disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11801269" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Acute bilateral optic disk edema with a macular star figure in a 12-year-old girl.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10583722" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Recurrent malignant hypertension: a report of two cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4026651" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Fundus lesions in malignant hypertension. II. A pathologic study of experimental hypertensive optic neuropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11918898" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The disk edema dilemma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15337197" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Endocrine and metabolic deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6160838" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Optic disc edema in juvenile-onset diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12476102" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Diabetic papillopathy in type II diabetic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12654358" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Anemia and papilledema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1841572" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13752497" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Optic neuritis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9176782" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Neuro-ophthalmic manifestations of Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12374502" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Bilateral neuroretinitis associated with mumps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14557195" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11589885" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cat-scratch disease neuroretinitis diagnosed by a polymerase chain reaction approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/677640" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Systemic lupus erythematosus presenting as optic neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10030579" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6696022" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Eleven cases of sarcoidosis of the optic nerve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13679663" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2378375" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The natural course of central retinal vein occlusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/727723" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Papillophlebitis: benign retinopathy resembling papilledema or papillitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5920162" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Papillophlebitis: a cause of protracted yet benign optic disc edema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12095830" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15085353" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Unilateral adult malignant optic nerve glioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3422790" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Leukemic involvement of the optic nerve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8600429" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15035387" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. 1966.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15537194" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8153376" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Radiation-induced injury to the visual pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6514295" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Factors affecting visual loss in benign intracranial hypertension.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
